Fibronectin levels in septicemic neonates before and after the administration of immunoglobulin.
Caliouli
C
C
Department of Paediatrics and Haematology, General Hospital of Pireus, Greece.
Liossis
G
G
Bakoleas
B
B
Lautaris
N
N
Costalos
C
C
D001667:Binding, Competitive; D005069:Evaluation Studies as Topic; D005353:Fibronectins / Q000097:blood* / Q000187:drug effects; D006801:Humans; D005779:Immunodiffusion; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000502:physiology* / Q000627:therapeutic use; D007231:Infant, Newborn; D007234:Infant, Premature; D008264:Macrophages / Q000276:immunology; D018805:Sepsis / Q000097:blood* / Q000276:immunology / Q000628:therapy
D005353:Fibronectins; D016756:Immunoglobulins, Intravenous